Tharakaram Ravishankar
Endocrinology, Diabetes & Metabolism · Glen Head, NYNPI 1083709794
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,708 of the $27,413 with a category attached, or 79.2%. Novo Nordisk accounts for 87.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $16,659 and has fallen 95.9% since, to $683 in 2022.
Across 158 payments — averaging $173.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$24K
- Boehringer Ingelheim$813
- Amgen$663
- AbbVie$397
- AstraZeneca$345
- Lilly USA, LLC$214
- plus $1K from 12 others
What the payments were for
- Speaking & faculty fees$21,70879%
- Travel & lodging$1,5396%
- Food & beverage$4,16615%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $23,857 |
| Boehringer Ingelheim | 26 | $813 |
| Amgen | 16 | $663 |
| AbbVie | 13 | $397 |
| AstraZeneca | 16 | $345 |
| Lilly USA, LLC | 9 | $214 |
| Mannkind Corporation | 3 | $185 |
| Sanofi-aventis U.S. LLC | 9 | $184 |
| Merck | 10 | $182 |
| Esperion Therapeutics, Inc. | 3 | $168 |
| Insulet Corporation | 7 | $135 |
| Bayer | 1 | $101 |
| Ultragenyx Pharmaceutical Inc. | 4 | $64 |
| IBSA Pharma Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Abbott | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,413 in reported general payments places this provider in the 85th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Other endocrinology, diabetes & metabolism in Glen Head
- Robert BuschAlbany$2.7M
- Michael ShanikSmithtown$1.2M
- Ajay ChaudhuriBuffalo$888K
- Vinay KapoorManhasset$820K
- John BilezikianNew York$809K
- Barbara HirschManhasset$746K
- Martin GrajowerBronx$713K
- Anastasios ManessisNew York$656K
- Jonas LeibowitzYonkers$613K
- Philip OtterbeckStaten Island$575K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.